Pelthos Therapeutics Inc. share price logo

Pelthos Therapeutics Inc.

NASDAQ: PTHS

$28.80

-0.11

(-0.38%)

Live

as on

Pelthos Therapeutics Inc. Stock Performance

as on August 14, 2026 at 3:33 am IST

  • Day's Low

    Day's High

    $25.83
    $29.80
    downward going graph

    10.31%

    Downside

    3.47%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $16.50
    $37.50
    downward going graph

    42.71%

    Downside

    30.21%

    Upside

    downward going graph

Pelthos Therapeutics Inc. share price movements today

Previous Close
$28.91
Open
$26.40
Volume
74.3K
Day's Low - High
$25.83 - $29.80
52 Week Low - High
$16.50 - $37.50

Pelthos Therapeutics Inc. Historical Returns

1 Month Return
+ 10.13 %
3 Month Return
+ 11.15 %
1 Year Return
+ 59.02 %
3 Year Return
0 %
5 Year Return
0 %

Pelthos Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Pelthos Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$100.5M

EPS (TTM)

-10.6625

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-333.84%

Pelthos Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pelthos Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$100.5MNANA-186.24%NA
BUY$44.0B703.05%NA0.00%NA
BUY$134.2B170.49%30.4935.00%NA
BUY$82.1B27.72%19.7327.87%0.44999999999999996%

Stock Returns calculator for Pelthos Therapeutics Inc. Stock including INR - Dollar returns

The Pelthos Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Pelthos Therapeutics Inc. investment value today

Current value as on today

₹1,72,872

Returns

₹72,872

(+72.87%)

Returns from Pelthos Therapeutics Inc. Stock

₹58,416 (+58.42%)

Dollar Impact

₹14,456 (+14.46%)

Indian Investors' Interest in Pelthos Therapeutics Inc. Stock

Search interest for Pelthos Therapeutics Inc. Stock has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-88% versus previous 30 day period

Pelthos Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
7
9
10
Gross Profit
-
-
-
-
-
-
2
4
5
Operating Income
-1
-1
-2
-1
-1
-3
-15
-12
-13
EBITDA
-1
-1
-1
-1
-1
-3
-14
-26
-6
Interest Expense
0
0
0
0
0
0
1
1
2
Depreciation
-
-
-
-
-
-
2
1
1
Income Before Tax
-2
-1
-1
-1
-1
-3
-16
-28
-10
Income Tax Expense
-
-
-
-
-
-
0
-6
-
Net Income
-2
-1
-1
-1
-1
-3
-16
-21
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-219.25%
-230.74%
-93.87%

Pelthos Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
-
-
-
16
Gross Profit
0
-
-
-
-
7
Operating Income
-1
0
-2
-6
-7
-32
EBITDA
0
0
-2
-6
-7
-45
Interest Expense
0
0
0
0
0
3
Depreciation
-
-
-
-
-
2
Income Before Tax
0
0
-2
-7
-7
-50
Income Tax Expense
-
-
-
-
-
-7
Net Income
0
0
-2
-7
-7
-43
Net Profit Margin
-330.40%
0.00%
0.00%
0.00%
0.00%
-257.93%

Pelthos Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-1
-1
-1
-1
-3
-16
-21
-10
Operating Cash Flow
-1
-2
0
0
0
0
-15
-6
-13
Investing Cash Flow
-
-
-
-
-
-
2
-7
0
Financing Cash Flow
5
1
0
0
0
0
26
18
27
Change in Cash
3
-1
-1
0
0
0
14
3
14

Pelthos Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-7
-7
-43
Operating Cash Flow
-1
0
-5
-22
Investing Cash Flow
-
-
-
-5
Financing Cash Flow
1
1
6
45
Change in Cash
0
0
0
17

Insights on Pelthos Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, PTHS stock has moved up by 40.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 469.1% return, outperforming this stock by 410.1%

About Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
OrganisationPelthos Therapeutics Inc.
Headquarters4020 Stirrup Creek Drive, Durham, NC, United States, 27703
IndustryBiotechnology
CEOMr. Scott M. Plesha
E-voting on sharesClick here to vote

Key Management of Pelthos Therapeutics Inc.

Name

Title

Mr. Scott M. Plesha

CEO, President & Director

Mr. Sai Rangarao M.B.A.

Chief Commercial Officer

Mr. John M. Gay CPA

CFO, Treasurer & Secretary

FAQs

What is Pelthos Therapeutics Inc. share price today?

Pelthos Therapeutics Inc. share price today is $28.80 as on . Pelthos Therapeutics Inc. share today touched a day high of $29.80 and a low of $25.83.

What is the 52 week high and 52 week low for Pelthos Therapeutics Inc. share?

Pelthos Therapeutics Inc. share touched a 52 week high of $37.50 on and a 52 week low of $16.50 on . Pelthos Therapeutics Inc. stock price today i.e. is trending at $28.80,which is 23.20% down from its 52 week high and 74.55% up from its 52 week low.

What is Pelthos Therapeutics Inc.'s market capitalisation today?

Pelthos Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Pelthos Therapeutics Inc. Stock (PTHS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pelthos Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pelthos Therapeutics Inc. Shares that will get you 0.0521 shares as per Pelthos Therapeutics Inc. share price of $28.80 per share as on August 13, 2026 at 10:03 pm IST.

What is the minimum amount required to buy Pelthos Therapeutics Inc. Stock (PTHS) from India?

Indian investors can start investing in Pelthos Therapeutics Inc. (PTHS) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Pelthos Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Pelthos Therapeutics Inc. share’s latest price of $28.80 as on August 13, 2026 at 10:03 pm IST, you will get 0.3472 shares of Pelthos Therapeutics Inc.. Learn more about fractional shares .